Johnson R L, Carey S C, Norman A W, Okamura W H
J Med Chem. 1977 Jan;20(1):5-11. doi: 10.1021/jm00211a002.
A homologous series of side-chain analogues of 25-hydroxyvitamin D3 (25-hydroxycholecalciferol) in which the length of the side chain is modified while maintaining its characteristic tertiary hydroxyl moiety has been synthesized. The following five analogues have been prepared and characterized: pentanor-25-OH-D3 (2a), trinor-25-OH-D3 (2b), dinor-25-OH-D3 (2c), nor-25-OH-D3 (2d), and homo-25-OH-D3 T2e). Biological assays in vivo of intestinal calcium absorption and bone calcium mobilization in the chick of the five analogues revealed that the homo analogue 2e exhibited a significant biological response relative to the -D (vitamin D3) control. Compared to the natural vitamin D3, 2e is as active in its ability to mobilize bone calcium and is about half as effective in stimulating intestinal calcium transport. The remaining analogues (2a-d) exhibited no significant activity in either assay, although the nor analogue 2d was previously observed to exhibit antimetabolite activity.
已合成了一系列25-羟基维生素D3(25-羟基胆钙化醇)的侧链类似物,其中侧链长度被改变,同时保持其特征性的叔羟基部分。已制备并表征了以下五种类似物:戊降-25-OH-D3(2a)、丁降-25-OH-D3(2b)、丙降-25-OH-D3(2c)、去甲-25-OH-D3(2d)和同型-25-OH-D3(2e)。对这五种类似物在雏鸡体内进行的肠道钙吸收和骨钙动员的生物学测定表明,同型类似物2e相对于维生素D3(-D)对照表现出显著的生物学反应。与天然维生素D3相比,2e在动员骨钙的能力方面同样活跃,在刺激肠道钙转运方面的效果约为其一半。其余类似物(2a-d)在任何一项测定中均未表现出显著活性,尽管之前观察到去甲类似物2d具有抗代谢物活性。